The efficacy of testosterone gel application for increases the sperm concentration in infertile men with oligospermia and low serum testosterone level

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20161030001

Enrollment

Unknown

Registered

2016-10-30

Start date

2016-04-19

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertile men with oligospermia and low serum testosterone level

Interventions

testosterone gel apply 2.5 ml. (12.5mg.) daily

Experimental Drug

testosterone gel

Eligibility

Sex/Gender

Male

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Infertile men with oligospermia (sperm concentration 18 years old

Exclusion criteria

Exclusion criteria: 1.Contraindication to study drug eg. prostatic cancer and breast cancer 2.Allergy to the study drug 3.Secondary cause of oligospermia include hydrocele, varicocele , hypogonadotropic hypogonadism and history of surgery at the testes 4.Previous used of testosterone replacement therapy

Design outcomes

Primary

Measure	Time frame
sperm concentration Every month semen analysis	—

Secondary

Measure	Time frame
sperm volume ,sperm motility , sperm morphology, serum testosterone and testosterone/estrogen ratio Every month semen analysis , serum testosterone	—

Countries

Thailand

Contacts

Public ContactPattraporn Chera-aree

Fellowship

liofird.oy@hotmial.com0868226131

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026